Natco Pharma Ltd (NATCOPHARM) Share Price Target Tomorrow| Prediction | Forecast for Intraday

loading widget to trade RELIGARE

The last closing price of NATCOPHARM is 624.45 at 04-Oct-22 3:30:00 PM. We are providing NATCOPHARM share price target on Intraday basis. These levels and targets calculated on the last 15mins candle. Current Support of NATCOPHARM is 619.4 and Resistance is 626.95 on 15mins basis.

Live NATCOPHARM share price target And Buy/Sell Levels

Last Updated at Last Price Buy Above Short Below
04-Oct-22 3:30:00 PM 624.45 626.95 619.4

For Intraday purpose:

Buying can be above 626.95 And NATCOPHARM share price target can be 630.71, 634.47, 639.49

Shorting can be below 619.4 And NATCOPHARM share price target can be 615.68, 611.97, 607.01

Click here for Best Shares to Buy
tomorrow for Intraday trading

This information is only for educational purpose, Please read carefully disclaimer of the website.

There is more information given below of the stock's detailed Technical analysis with the help of all indicators.

Technical Analysis of NATCOPHARM

Last Updated at: 04-Oct-22 9:15:00 AM

Short Moving Average(21 Days)

NATCOPHARM is Bullish on short moving average. Short moving average period is 21 Days.

Medium Moving Average(50 Days)

NATCOPHARM is Bearish on Medium moving average. Medium moving average period is 50 Days.

Long Moving Average(100 Days)

NATCOPHARM is Bearish on Long moving average. Medium moving average period is 100 Days.


NATCOPHARM is Bullish on MACD indicator. MACD Stands for Moving Average Convergence Divergence.It is a trend following momentum indicator. For calculation three moving averages are taken which are 9 day EMA, 12 day EMA & 26 day EMA.


NATCOPHARM is Bearish on Aroon indicator. The Aroon indicator is a technical indicator that is used to identify trend changes in the price of an asset, as well as the strength of that trend. In essence, the indicator measures the time between highs and the time between lows over a time period


NATCOPHARM is Bullish on Stochastic indicator.

Bolinger Band

NATCOPHARM is Neutral on Bolinger Band.
Sector: Health Technology
Industry: Pharmaceuticals: Major
Employees: 5455
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO’s critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.